{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T02:09:16Z","timestamp":1795140556835,"version":"4.10.3"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":1053,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Intensive Care"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1186\/s13613-023-01109-w","type":"journal-article","created":{"date-parts":[[2023,3,12]],"date-time":"2023-03-12T04:02:42Z","timestamp":1678593762000},"page":"17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["Intravenously administered interleukin-7 to reverse lymphopenia in patients with septic shock: a double-blind, randomized, placebo-controlled trial"],"prefix":"10.1016","volume":"13","clinical-trial-number":[{"clinical-trial-number":"nct03821038","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Thomas","family":"Daix","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armelle","family":"Mathonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Brakenridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Fran\u00e7ois","family":"Dequin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Mira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederique","family":"Berbille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Morre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Jeannet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Blood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Unsinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Blood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Walton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyle L.","family":"Moldawer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Hotchkiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2531-1652","authenticated-orcid":false,"given":"Bruno","family":"Fran\u00e7ois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1186\/s13613-023-01109-w_bb0010","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1097\/00003246-199907000-00002","article-title":"Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction","volume":"27","author":"Hotchkiss","year":"1999","journal-title":"Crit Care Med"},{"issue":"9","key":"10.1186\/s13613-023-01109-w_bb0015","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1080\/00365540310015692","article-title":"Role of apoptotic cell death in sepsis","volume":"35","author":"Hotchkiss","year":"2003","journal-title":"Scand J Infect Dis"},{"issue":"2","key":"10.1186\/s13613-023-01109-w_bb0020","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1189\/jlb.0105017","article-title":"Leukocyte apoptosis and its significance in sepsis and shock","volume":"78","author":"Wesche","year":"2005","journal-title":"J Leukoc Biol"},{"issue":"11","key":"10.1186\/s13613-023-01109-w_bb0025","doi-asserted-by":"crossref","first-page":"6952","DOI":"10.4049\/jimmunol.166.11.6952","article-title":"Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans","volume":"166","author":"Hotchkiss","year":"2001","journal-title":"J Immunol"},{"issue":"5","key":"10.1186\/s13613-023-01109-w_bb0030","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/SHK.0000000000000234","article-title":"Persistent lymphopenia after diagnosis of sepsis predicts mortality","volume":"42","author":"Drewry","year":"2014","journal-title":"Shock"},{"issue":"3","key":"10.1186\/s13613-023-01109-w_bb0035","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/CCM.0b013e318274645f","article-title":"Reduction of immunocompetent T cells followed by prolonged lymphopenia in severe sepsis in the elderly","volume":"41","author":"Inoue","year":"2013","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1186\/s13613-023-01109-w_bb0040","doi-asserted-by":"crossref","first-page":"R192","DOI":"10.1186\/cc9309","article-title":"Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit","volume":"14","author":"de Jager","year":"2010","journal-title":"Crit Care"},{"issue":"10","key":"10.1186\/s13613-023-01109-w_bb0045","doi-asserted-by":"crossref","first-page":"5073","DOI":"10.4049\/jimmunol.1202062","article-title":"IL-7 restores lymphocyte functions in septic patients","volume":"189","author":"Venet","year":"2012","journal-title":"J Immunol"},{"issue":"8","key":"10.1186\/s13613-023-01109-w_bb0050","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.4049\/jimmunol.174.8.5110","article-title":"Accelerated lymphocyte death in sepsis occurs by both the death receptor and mitochondrial pathways","volume":"174","author":"Hotchkiss","year":"2005","journal-title":"J Immunol"},{"issue":"4","key":"10.1186\/s13613-023-01109-w_bb0055","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/SHK.0b013e3181dc0977","article-title":"Early assessment of leukocyte alterations at diagnosis of septic shock","volume":"34","author":"Venet","year":"2010","journal-title":"Shock"},{"issue":"6","key":"10.1186\/s13613-023-01109-w_bb0060","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/00024382-200212000-00001","article-title":"Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome","volume":"18","author":"Le Tulzo","year":"2002","journal-title":"Shock"},{"issue":"2","key":"10.1186\/s13613-023-01109-w_bb0065","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1182\/blood.V93.2.467","article-title":"Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions","volume":"93","author":"Small","year":"1999","journal-title":"Blood"},{"issue":"7","key":"10.1186\/s13613-023-01109-w_bb0070","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.4049\/jimmunol.0903151","article-title":"IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis","volume":"184","author":"Unsinger","year":"2010","journal-title":"J Immunol"},{"key":"10.1186\/s13613-023-01109-w_bb0075","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98960","article-title":"Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial","author":"Francois","year":"2018","journal-title":"JCI Insight"},{"issue":"2","key":"10.1186\/s13613-023-01109-w_bb0080","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMra021333","article-title":"The pathophysiology and treatment of sepsis","volume":"348","author":"Hotchkiss","year":"2003","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1186\/s13613-023-01109-w_bb0085","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1001\/jama.2011.1829","article-title":"Immunosuppression in patients who die of sepsis and multiple organ failure","volume":"306","author":"Boomer","year":"2011","journal-title":"JAMA"},{"key":"10.1186\/s13613-023-01109-w_bb0090","doi-asserted-by":"crossref","unstructured":"Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine. Chest 1992;101:1644\u201355","DOI":"10.1378\/chest.101.6.1644"},{"issue":"12","key":"10.1186\/s13613-023-01109-w_bb0095","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1093\/jac\/dkq359","article-title":"A case of progressive multifocal leukoencephalopathy and idiopathic CD4+ lymphocytopenia","volume":"65","author":"Patel","year":"2010","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"10.1186\/s13613-023-01109-w_bb0100","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1001\/jamaneurol.2014.825","article-title":"Treatment of progressive multifocal leukoencephalopathy with interleukin 7","volume":"71","author":"Alstadhaug","year":"2014","journal-title":"JAMA Neurol"},{"issue":"6","key":"10.1186\/s13613-023-01109-w_bb0105","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/ofid\/ofab256","article-title":"IL-7 immunotherapy in a nonimmunocompromised patient with intractable fungal wound sepsis","volume":"8","author":"Turnbull","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"10.1186\/s13613-023-01109-w_bb0110","first-page":"e0500","article-title":"Interleukin-7 reverses lymphopenia and improves T-cell function in Coronavirus disease 2019 patient with inborn error of toll-like receptor 3: a case report","volume":"3","author":"Mazer","year":"2021","journal-title":"Crit Care Explor"},{"issue":"1","key":"10.1186\/s13613-023-01109-w_bb0115","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/AAC.43.1.21","article-title":"Close association between clearance of recombinant human granulocyte colony-stimulating factor (G-CSF) and G-CSF receptor on neutrophils in cancer patients","volume":"43","author":"Terashi","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1186\/s13613-023-01109-w_bb0120","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1023\/A:1014414520282","article-title":"General pharmacokinetic model for drugs exhibiting target-mediated drug disposition","volume":"28","author":"Mager","year":"2001","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"6","key":"10.1186\/s13613-023-01109-w_bb0125","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10928-007-9074-0","article-title":"Target-mediated pharmacokinetic and pharmacodynamic model of recombinant human erythropoietin (rHuEPO)","volume":"34","author":"Woo","year":"2007","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"2","key":"10.1186\/s13613-023-01109-w_bb0130","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nri2023","article-title":"Interleukin-7 receptor expression: intelligent design","volume":"7","author":"Mazzucchelli","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"10.1186\/s13613-023-01109-w_bb0135","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/s41590-019-0479-x","article-title":"Flip the coin: IL-7 and IL-7R in health and disease","volume":"20","author":"Barata","year":"2019","journal-title":"Nat Immunol"},{"issue":"23","key":"10.1186\/s13613-023-01109-w_bb0140","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1182\/blood-2017-12-823757","article-title":"First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation","volume":"131","author":"Romee","year":"2018","journal-title":"Blood"},{"issue":"3","key":"10.1186\/s13613-023-01109-w_bb0145","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/01.cji.0000210386.55951.c2","article-title":"IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells","volume":"29","author":"Rosenberg","year":"2006","journal-title":"J Immunother"},{"issue":"8","key":"10.1186\/s13613-023-01109-w_bb0150","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1182\/blood-2015-05-645077","article-title":"Administration of interleukin-7 increases CD4 T cells in idiopathic CD4 lymphocytopenia","volume":"127","author":"Sheikh","year":"2016","journal-title":"Blood"},{"issue":"25","key":"10.1186\/s13613-023-01109-w_bb0155","doi-asserted-by":"crossref","first-page":"6304","DOI":"10.1182\/blood-2008-10-186601","article-title":"IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection","volume":"113","author":"Sereti","year":"2009","journal-title":"Blood"},{"issue":"24","key":"10.1186\/s13613-023-01109-w_bb0160","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1182\/blood-2012-06-437236","article-title":"Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation","volume":"120","author":"Perales","year":"2012","journal-title":"Blood"},{"issue":"2","key":"10.1186\/s13613-023-01109-w_bb0165","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/cid\/cis383","article-title":"Effects of recombinant human interleukin 7 on T-cell recovery and thymic output in HIV-infected patients receiving antiretroviral therapy: results of a phase I\/IIa randomized, placebo-controlled, multicenter study","volume":"55","author":"Levy","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1186\/s13613-023-01109-w_bb0170","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20071681","article-title":"Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets","volume":"205","author":"Sportes","year":"2008","journal-title":"J Exp Med"},{"issue":"7","key":"10.1186\/s13613-023-01109-w_bb0175","doi-asserted-by":"crossref","first-page":"e2016485","DOI":"10.1001\/jamanetworkopen.2020.16485","article-title":"Association of interleukin 7 immunotherapy with lymphocyte counts among patients with severe Coronavirus disease 2019 (COVID-19)","volume":"3","author":"Laterre","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1186\/s13613-023-01109-w_bb0180","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1182\/blood-2008-11-191288","article-title":"Injection of glycosylated recombinant simian IL-7 provokes rapid and massive T-cell homing in rhesus macaques","volume":"114","author":"Beq","year":"2009","journal-title":"Blood"},{"issue":"4","key":"10.1186\/s13613-023-01109-w_bb0185","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1182\/blood-2009-04-217091","article-title":"Where have all the T cells gone?","volume":"114","author":"Sereti","year":"2009","journal-title":"Blood"}],"container-title":["Annals of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-023-01109-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13613-023-01109-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025003425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025003425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-023-01109-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:44:55Z","timestamp":1776671095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2110582025003425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"alternative-id":["S2110582025003425"],"URL":"https:\/\/doi.org\/10.1186\/s13613-023-01109-w","relation":{},"ISSN":["2110-5820"],"issn-type":[{"value":"2110-5820","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenously administered interleukin-7 to reverse lymphopenia in patients with septic shock: a double-blind, randomized, placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Annals of Intensive Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1186\/s13613-023-01109-w","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 The Author(s) 2023. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}],"article-number":"17"}}